Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: Experience at Rizzoli on 1421 patients treated over the last 30 years

Gaetano Bacci, Alessandra Longhi, Stefano Ferrari, Antonio Briccoli, Davide Donati, Massimiliano De Paolis, Michela Versari

Research output: Contribution to journalArticle

Abstract

Aims: The study evaluated the correlation between pretreatment serum lactate dehydrogenase (LDH) levels with the stage of disease and its clinical prognostic value. Methods: Pretreatment serum LDH of 1421 patients with osteosarcoma of the extremity were assessed to investigate whether the enzyme correlates with the stage of the tumor. In 860 assessable patients with localized disease, treated according to 10 different protocols of adjuvant (four) and neoadjuvant chemotherapy (six), we also evaluated the correlation between the serum levels of LDH and outcome. Results: According to the stage of disease, the rate of high serum level of LDH was significantly higher in 199 patients with metastatic disease at presentation than in 1222 patients with localized disease (36.6% vs 18.8%; P

Original languageEnglish
Pages (from-to)478-484
Number of pages7
JournalTumori
Volume90
Issue number5
Publication statusPublished - Sep 2004

Keywords

  • Osteosarcoma
  • Prognosis
  • Serum lactate dehydrogenase

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: Experience at Rizzoli on 1421 patients treated over the last 30 years'. Together they form a unique fingerprint.

  • Cite this